Brooks Laboratories Ltd

Brooks Lab. Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Brooks Laboratories Ltd

₹ 130 -2.44%
09 Jun 10:40 a.m.
brookslabs.net BSE: 533543 NSE: BROOKS
About

Incorporated in 2002, Brooks Laboratories Ltd is a pharmaceutical company working on contract basis catering to the critical care segment[1]

Key Points

Business Overview:[1]
BLL is an EU GMP & ISO 9001:2008 certified manufacturer and marketer of pharmaceutical formulations

Website BSE NSE - BE
  • Market Cap ₹ 383 Cr.
  • Current Price ₹ 130
  • High / Low ₹ 203 / 77.3
  • Stock P/E 126
  • Book Value ₹ 39.1
  • Dividend Yield 0.00 %
  • ROCE 4.31 %
  • ROE 3.30 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company is almost debt free.

Cons

  • Stock is trading at 3.40 times its book value
  • Though the company is reporting repeated profits, it is not paying out dividend
  • Promoter holding has decreased over last quarter: -6.44%
  • The company has delivered a poor sales growth of 3.45% over past five years.
  • Tax rate seems low
  • Company has a low return on equity of -1.67% over last 3 years.
  • Working capital days have increased from 41.6 days to 70.7 days

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
21.31 14.94 15.89 12.00 12.61 15.70 24.32 21.75 17.72 17.93 20.79 20.52 23.32
20.98 18.98 16.16 13.47 12.74 15.67 22.60 20.66 17.34 17.65 19.28 18.95 21.74
Operating Profit 0.33 -4.04 -0.27 -1.47 -0.13 0.03 1.72 1.09 0.38 0.28 1.51 1.57 1.58
OPM % 1.55% -27.04% -1.70% -12.25% -1.03% 0.19% 7.07% 5.01% 2.14% 1.56% 7.26% 7.65% 6.78%
0.37 0.05 0.07 0.06 0.03 0.05 0.09 0.16 0.65 0.07 0.20 0.03 0.62
Interest 0.23 0.16 0.19 0.24 0.18 0.17 0.19 0.21 0.27 0.16 0.32 0.28 0.26
Depreciation 0.42 0.42 0.43 0.43 0.44 0.44 0.44 0.43 0.46 0.40 0.43 0.38 0.39
Profit before tax 0.05 -4.57 -0.82 -2.08 -0.72 -0.53 1.18 0.61 0.30 -0.21 0.96 0.94 1.55
Tax % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 4.92% 0.00% 0.00% 0.00% 0.00% 11.61%
0.05 -4.57 -0.82 -2.08 -0.71 -0.53 1.18 0.58 0.30 -0.21 0.96 0.94 1.37
EPS in Rs 0.02 -1.74 -0.31 -0.79 -0.27 -0.20 0.45 0.22 0.11 -0.08 0.37 0.36 0.47
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
85.27 85.21 80.01 57.54 55.71 55.03 69.69 76.66 76.97 55.54 79.49 82.56
76.75 78.36 68.93 52.50 64.64 63.40 72.27 75.65 75.10 61.36 76.28 77.58
Operating Profit 8.52 6.85 11.08 5.04 -8.93 -8.37 -2.58 1.01 1.87 -5.82 3.21 4.98
OPM % 9.99% 8.04% 13.85% 8.76% -16.03% -15.21% -3.70% 1.32% 2.43% -10.48% 4.04% 6.03%
0.00 5.04 1.69 0.12 0.24 2.88 -0.94 0.90 0.95 0.12 0.96 0.88
Interest 0.12 0.44 0.79 1.01 2.40 2.96 3.35 3.25 0.67 0.77 0.84 1.03
Depreciation 0.83 1.10 1.16 1.67 6.45 6.50 6.65 7.09 1.49 1.72 1.77 1.60
Profit before tax 7.57 10.35 10.82 2.48 -17.54 -14.95 -13.52 -8.43 0.66 -8.19 1.56 3.23
Tax % 4.36% 8.50% 1.66% 33.06% -21.21% -0.94% 80.33% 84.82% 0.00% 0.00% 1.92% 5.57%
7.24 9.47 10.63 1.67 -13.81 -14.81 -24.38 -15.59 0.67 -8.18 1.53 3.05
EPS in Rs 2.91 3.80 4.27 0.67 -5.55 -5.95 -9.31 -5.95 0.26 -3.12 0.58 1.04
Dividend Payout % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Compounded Sales Growth
10 Years: 0%
5 Years: 3%
3 Years: 2%
TTM: 4%
Compounded Profit Growth
10 Years: -8%
5 Years: 16%
3 Years: 95%
TTM: 101%
Stock Price CAGR
10 Years: 14%
5 Years: 33%
3 Years: 10%
1 Year: 72%
Return on Equity
10 Years: -6%
5 Years: -5%
3 Years: -2%
Last Year: 3%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 16.19 16.19 16.19 16.19 16.19 16.19 24.70 24.70 24.70 24.70 26.25 29.46
Reserves 96.10 95.23 105.86 112.09 98.29 88.96 73.71 39.51 40.30 32.08 43.28 85.61
0.14 0.51 5.71 13.72 27.98 31.18 27.64 8.40 5.97 6.51 5.64 7.58
20.04 23.61 24.77 22.13 30.21 31.55 31.81 20.39 32.48 29.13 19.22 18.01
Total Liabilities 132.47 135.54 152.53 164.13 172.67 167.88 157.86 93.00 103.45 92.42 94.39 140.66
20.15 15.68 16.34 125.95 124.64 117.70 113.02 14.96 15.14 15.01 13.67 13.98
CWIP 37.16 52.86 86.86 0.00 0.52 0.29 0.11 0.02 1.12 0.00 0.00 0.00
Investments 0.02 0.02 0.02 0.02 0.02 0.02 0.02 46.81 46.84 46.85 46.86 90.52
75.14 66.98 49.31 38.16 47.49 49.87 44.71 31.21 40.35 30.56 33.86 36.16
Total Assets 132.47 135.54 152.53 164.13 172.67 167.88 157.86 93.00 103.45 92.42 94.39 140.66

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
10.65 2.13 8.12 9.56 -6.18 -5.05 -9.39 -0.90 3.12 0.55 -9.68 2.52
-10.64 -1.12 -13.56 -16.80 -5.14 1.12 -2.33 -0.74 1.12 -0.40 0.18 -45.97
0.29 -0.07 4.32 7.01 11.82 5.78 9.61 1.31 -4.23 -0.21 9.60 43.36
Net Cash Flow 0.30 0.94 -1.12 -0.23 0.51 1.85 -2.10 -0.33 0.02 -0.06 0.10 -0.08

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 70.46 82.63 86.27 67.81 66.70 75.75 81.50 45.66 71.27 83.79 74.94 88.38
Inventory Days 37.59 45.32 46.12 75.53 103.93 93.03 107.30 91.81 119.53 99.41 60.49 62.10
Days Payable 99.87 114.65 108.29 180.19 242.76 251.23 203.15 99.30 185.53 205.59 97.25 91.94
Cash Conversion Cycle 8.18 13.30 24.09 -36.85 -72.12 -82.45 -14.35 38.17 5.28 -22.39 38.18 58.54
Working Capital Days 29.45 43.82 23.13 -13.00 -20.97 -29.85 17.96 27.76 26.65 -3.81 57.81 70.74
ROCE % 7.03% 7.24% 9.58% 2.59% -10.64% -8.72% -6.72% -5.15% 1.49% -11.07% 3.45% 4.31%

Shareholding Pattern

Numbers in percentages

Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025
66.41% 66.41% 66.41% 66.41% 66.41% 63.59% 63.59% 63.59% 63.59% 63.59% 59.06% 52.62%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.02% 0.01% 0.05%
0.00% 0.00% 0.00% 0.00% 0.00% 2.46% 3.86% 3.86% 3.86% 3.86% 3.86% 10.38%
33.59% 33.58% 33.59% 33.59% 33.58% 33.94% 32.56% 32.55% 32.55% 32.53% 37.08% 36.95%
No. of Shareholders 11,10410,52410,41010,70911,21610,68610,02811,43211,54311,28210,52110,537

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Right Issue

Credit ratings